|
1
|
Griffiths-Jones S: The microRNA registry.
Nucleic Acids Res. 32:D109–D111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim Y and Kim VN: MicroRNA factory: RISC
assembly from precursor microRNAs. Mol Cell. 46:384–386. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meister G, Landthaler M, Patkaniowska A,
Dorsett Y, Teng G and Tuschl T: Human Argonaute2 mediates RNA
cleavage targeted by miRNAs and siRNAs. Mol Cell. 15:185–197. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fabian MR, Mathonnet G, Sundermeier T,
Mathys H, Zipprich JT, Svitkin YV, Rivas F, Jinek M, Wohlschlegel
J, Doudna JA, et al: Mammalian miRNA RISC recruits CAF1 and PABP to
affect PABP-dependent deadenylation. Mol Cell. 35:868–880. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Emde A and Hornstein E: miRNAs at the
interface of cellular stress and disease. EMBO J. 33:1428–1437.
2014.PubMed/NCBI
|
|
8
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kulshreshtha R, Davuluri RV, Calin GA and
Ivan M: A microRNA component of the hypoxic response. Cell Death
Differ. 15:667–671. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kulshreshtha R, Ferracin M, Negrini M,
Calin GA, Davuluri RV and Ivan M: Regulation of microRNA
expression: The hypoxic component. Cell Cycle. 6:1426–1431. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang X and Zuo J: Emerging roles of
miR-210 and other non-coding RNAs in the hypoxic response. Acta
Biochim Biophys Sin (Shanghai). 46:220–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Devlin C, Greco S, Martelli F and Ivan M:
miR-210: More than a silent player in hypoxia. IUBMB Life.
63:94–100. 2011.PubMed/NCBI
|
|
13
|
Camps C, Buffa FM, Colella S, Moore J,
Sotiriou C, Sheldon H, Harris AL, Gleadle JM and Ragoussis J:
Hsa-miR-210 is induced by hypoxia and is an independent prognostic
factor in breast cancer. Clin Cancer Res. 14:1340–1348. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gee HE, Camps C, Buffa FM, Patiar S,
Winter SC, Betts G, Homer J, Corbridge R, Cox G, West CM, et al:
Hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in
head and neck cancer. Cancer. 116:2148–2158. 2010.PubMed/NCBI
|
|
15
|
Greither T, Grochola LF, Udelnow A,
Lautenschläger C, Würl P and Taubert H: Elevated expression of
microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated
with poorer survival. Int J Cancer. 126:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Greither T, Würl P, Grochola L, Bond G,
Bache M, Kappler M, Lautenschläger C, Holzhausen HJ, Wach S, Eckert
AW and Taubert H: Expression of microRNA 210 associates with poor
survival and age of tumor onset of soft-tissue sarcoma patients.
Int J Cancer. 130:1230–1235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baumgarten A, Bang C, Tschirner A,
Engelmann A, Adams V, von Haehling S, Doehner W, Pregla R, Anker
MS, Blecharz K, et al: TWIST1 regulates the activity of ubiquitin
proteasome system via the miR-199/214 cluster in human end-stage
dilated cardiomyopathy. Int J Cardiol. 168:1447–1452. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rane S, He M, Sayed D, Vashistha H,
Malhotra A, Sadoshima J, Vatner DE, Vatner SF and Abdellatif M:
Downregulation of miR-199a derepresses hypoxia-inducible
factor-1alpha and Sirtuin 1 and recapitulates hypoxia
preconditioning in cardiac myocytes. Circ Res. 104:879–886. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Song B, Song W, Liu J, Sun A, Wu
D, Yu H, Lian J, Chen L and Han J: Underexpressed microRNA-199b-5p
targets hypoxia-inducible factor-1α in hepatocellular carcinoma and
predicts prognosis of hepatocellular carcinoma patients. J
Gastroenterol Hepatol. 26:1630–1637. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen BF, Suen YK, Gu S, Li L and Chan WY:
A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and
DNMT1 in testicular germ cell tumor. Sci Rep. 4:64132014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He J, Jing Y, Li W, Qian X, Xu Q, Li FS,
Liu LZ, Jiang BH and Jiang Y: Roles and mechanism of miR-199a and
miR-125b in tumor angiogenesis. PLoS One. 8:e566472013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding G, Huang G, Liu HD, Liang HX, Ni YF,
Ding ZH, Ni GY and Hua HW: MiR-199a suppresses the hypoxia-induced
proliferation of non-small cell lung cancer cells through targeting
HIF1α. Mol Cell Biochem. 384:173–180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang X, Lei S, Long J, Liu X and Wu Q:
MicroRNA-199a-5p inhibits tumor proliferation in melanoma by
mediating HIF-1α. Mol Med Rep. 13:5241–5247. 2016.PubMed/NCBI
|
|
24
|
Kappler M, Köhler T, Kampf C,
Diestelkötter P, Würl P, Schmitz M, Bartel F, Lautenschläger C,
Rieber EP, Schmidt H, et al: Increased survivin transcript levels:
An independent negative predictor of survival in soft tissue
sarcoma patients. Int J Cancer. 95:360–363. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Würl P, Kappler M, Meye A, Bartel F,
Köhler T, Lautenschläger C, Bache M, Schmidt H and Taubert H:
Co-expression of survivin and TERT and risk of tumour-related death
in patients with soft-tissue sarcoma. Lancet. 359:943–945. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi R and Chiang VL: Facile means for
quantifying microRNA expression by real-time PCR. Biotechniques.
39:519–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guled M, Pazzaglia L, Borze I, Mosakhani
N, Novello C, Benassi MS and Knuutila S: Differentiating soft
tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A
miRNA analysis. Genes Chromosomes Cancer. 53:693–702. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim
JH, Kim JW and Kim S: MicroRNA expression profiles in serous
ovarian carcinoma. Clin Cancer Res. 14:2690–2695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sanfiorenzo C, Ilie MI, Belaid A, Barlési
F, Mouroux J, Marquette CH, Brest P and Hofman P: Two panels of
plasma microRNAs as non-invasive biomarkers for prediction of
recurrence in resectable NSCLC. PLoS One. 8:e545962013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Si T, Liu C, Xu K and Gui Y: Association
of miR-199a expression with clinicopathologic characteristics and
prognosis of renal cell carcinoma. Nan Fang Yi Ke Da Xue Xue Bao.
32:1568–1571. 2012.(In Chinese). PubMed/NCBI
|
|
32
|
Fornari F, Milazzo M, Chieco P, Negrini M,
Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L and Gramantieri
L: MiR-199a-3p regulates mTOR and c-Met to influence the
doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res.
70:5184–5193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tian R, Xie X, Han J, Luo C, Yong B, Peng
H, Shen J and Peng T: miR-199a-3p negatively regulates the
progression of osteosarcoma through targeting AXL. Am J Cancer Res.
4:738–750. 2014.PubMed/NCBI
|
|
34
|
Wan D, He S, Xie B, Xu G, Gu W, Shen C, Hu
Y, Wang X, Zhi Q and Wang L: Aberrant expression of miR-199a-3p and
its clinical significance in colorectal cancers. Med Oncol.
30:3782013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feber A, Xi L, Pennathur A, Gooding WE,
Bandla S, Wu M, Luketich JD, Godfrey TE and Litle VR: MicroRNA
prognostic signature for nodal metastases and survival in
esophageal adenocarcinoma. Ann Thorac Surg. 91:1523–1530. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang Y, Zhu Y, Wang X, Gong J, Hu C, Guo
B, Zhu B and Li Y: Temporal regulation of HIF-1 and NF-κB in
hypoxic hepatocarcinoma cells. Oncotarget. 6:9409–9419. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Joshi HP, Subramanian IV, Schnettler EK,
Ghosh G, Rupaimoole R, Evans C, Saluja M, Jing Y, Cristina I, Roy
S, et al: Dynamin 2 along with microRNA-199a reciprocally regulate
hypoxia-inducible factors and ovarian cancer metastasis. Proc Natl
Acad Sci USA. 111:5331–5336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mizuno S, Bogaard HJ, Gomez-Arroyo J,
Alhussaini A, Kraskauskas D, Cool CD and Voelkel NF:
MicroRNA-199a-5p is associated with hypoxia-inducible factor-1α
expression in lungs from patients with COPD. Chest. 142:663–672.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Raimondi L, Amodio N, Di Martino MT,
Altomare E, Leotta M, Caracciolo D, Gullà A, Neri A, Taverna S,
D'Aquila P, et al: Targeting of multiple myeloma-related
angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor
activity. Oncotarget. 5:3039–3054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rane S, He M, Sayed D, Yan L, Vatner D and
Abdellatif M: An antagonism between the AKT and beta-adrenergic
signaling pathways mediated through their reciprocal effects on
miR-199a-5p. Cell Signal. 22:1054–1062. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yeligar S, Tsukamoto H and Kalra VK:
Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal
endothelial cells and human endothelial cells involves
hypoxia-inducible factor-1alpha and microrNA-199. J Immunol.
183:5232–5243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Murakami Y, Toyoda H, Tanaka M, Kuroda M,
Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T and Shimotohno K:
The progression of liver fibrosis is related with overexpression of
the miR-199 and 200 families. PLoS One. 6:e160812011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
He J, Xu Q, Jing Y, Agani F, Qian X,
Carpenter R, Li Q, Wang XR, Peiper SS, Lu Z, et al: Reactive oxygen
species regulate ERBB2 and ERBB3 expression via miR-199a/125b and
DNA methylation. EMBO Rep. 13:1116–1122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kinose Y, Sawada K, Nakamura K, Sawada I,
Toda A, Nakatsuka E, Hashimoto K, Mabuchi S, Takahashi K, Kurachi
H, et al: The hypoxia-related microRNA miR-199a-3p displays tumor
suppressor functions in ovarian carcinoma. Oncotarget.
6:11342–11356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tauchi H, Matsuura S, Isomura M, Kinjo T,
Nakamura A, Sakamoto S, Kondo N, Endo S, Komatsu K and Nakamura Y:
Sequence analysis of an 800-kb genomic DNA region on chromosome
8q21 that contains the Nijmegen breakage syndrome gene, NBS1.
Genomics. 55:242–247. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ong CK, Ng CY, Leong C, Ng CP, Foo KT, Tan
PH and Huynh H: Genomic structure of human OKL38 gene and its
differential expression in kidney carcinogenesis. J Biol Chem.
279:743–754. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Defamie V, Cursio R, Le Brigand K,
Moreilhon C, Saint-Paul MC, Laurens M, Crenesse D, Cardinaud B,
Auberger P, Gugenheim J, et al: Gene expression profiling of human
liver transplants identifies an early transcriptional signature
associated with initial poor graft function. Am J Transplant.
8:1221–1236. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kao J, Salari K, Bocanegra M, Choi YL,
Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar
AF, et al: Molecular profiling of breast cancer cell lines defines
relevant tumor models and provides a resource for cancer gene
discovery. PLoS One. 4:e61462009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Raharijaona M, Le Pennec S, Poirier J,
Mirebeau-Prunier D, Rouxel C, Jacques C, Fontaine JF, Malthiery Y,
Houlgatte R and Savagner F: PGC-1-related coactivator modulates
mitochondrial-nuclear crosstalk through endogenous nitric oxide in
a cellular model of oncocytic thyroid tumours. PLoS One.
4:e79642009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
van Unnik JA, Coindre JM, Contesso C,
Lutter CE Albus, Schiodt T, Sylvester R, Thomas D, Bramwell V and
Mouridsen HT: Grading of soft tissue sarcomas: Experience of the
EORTC soft tissue and bone sarcoma group. Eur J Cancer 29A.
2089–2093. 1993. View Article : Google Scholar
|
|
51
|
Weiss SW and Goldblum JR: Malignant soft
tissue tumors of uncertain typeEnzinger and Weiss's Soft Tissue
Tumors. 5th. Mosby Elsevier; Philadelphia, PA: pp. 3–8. 2008
|
